ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1411	National Cancer Institute	Html	en	Lung Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing lung cancer and about research aimed at the prevention of this disease.	lung cancer screening 0.598829 beta-carotene cancer prevention 0.582664 Retinol Efficacy Trial 0.5493 World Cancer Research 0.557661 radiation-induced cancer risk 0.558005 Cancer Statistics Review 0.554669 Engl J Med 0.601423 lung cancer 0.940569 American Cancer Society 0.565044 new cancer cases 0.561841 cancer prevention study 0.562495 Lung cancer deaths 0.600217 Int J Cancer 0.549565 tobacco-specific lung carcinogen 0.591137 lung cancer survival 0.624991 lung cancers 0.566409 smoking-caused lung cancer 0.618173 Natl Cancer Inst 0.828608 increase lung cancer 0.607425 Clin Cancer Res 0.548805 lung cancer risks. 0.611661 et al. 0.610801 women 0.552318 lung cancer burden 0.611188 lung cancer risks 0.615545	Cancer Epidemiol Biomarkers 0.562574 Cancer Research Fund/American 0.55766 PUBMED Abstract 0.579028 cigarette smoking 0.565154 lung cancer rates 0.635876 National Cancer Institute 0.583038 high lung cancer 0.622636 primary lung cancer 0.607733 Abstract 0.640461 lung adenocarcinoma 0.566862 breast cancer 0.562844 5-year lung cancer 0.61828 breast cancer radiotherapy 0.549181 lung cancer. 0.565606 physical activity 0.552389 Carotene Cancer Prevention 0.55106 lung cancer risk 0.779552 Low-dose lung 0.559226 increases lung cancer 0.60774 lung cancer risk. 0.61153 Public Health Service 0.550531 lung cancer mortality 0.61452 lung cancer incidence 0.71571 air pollution 0.563747	CLICK HERE
1441	National Cancer Institute	Html	en	Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult acute lymphoblastic leukemia.	Italy Leukemia Group 0.492562 bcr-abl tyrosine kinase 0.570934 adults 0.459185 earlier marrow regeneration 0.455938 allogeneic bone marrow 0.517214 acute lymphoid leukemias 0.472448 remission induction 0.47757 Gale RP 0.454812 imatinib mesylate 0.472156 chemotherapy 0.474627 Engl J Med 0.498791 bone marrow transplantation 0.48642 tyrosine kinase inhibitors 0.483263 Rapid marrow ablation 0.456209 acute myeloid leukemia 0.613636 leukemia group 0.516396 Adult Leukemia Study 0.500665 acute lymphocytic leukemia 0.648415 reverse-transcriptase polymerase chain 0.482354 Burkitt leukemia 0.499236 chronic myeloid leukemia 0.493376 remission rate 0.456311 remission induction regimen 0.463491 polymerase chain reaction 0.48041	bone marrow transplant 0.489602 white blood cell 0.478936 different fusion protein 0.477591 chromosomal abnormalities 0.455367 bone marrow biopsy 0.472092 Abstract 0.51225 patients 0.592026 hairy cell leukemia 0.509021 Clin Oncol 0.480632 chronic myelogenous leukemia 0.543537 bone marrow 0.65205 Philadelphia chromosome 0.465482 complete response rate 0.474063 remission induction treatment 0.472074 acute lymphoblastic leukemia 0.938565 complete remission 0.520144 bcr-abl fusion gene 0.592307 acute leukemia 0.555648 complete remission status 0.464197 High complete remission 0.459577 marrow remission 0.460989 bone marrow transplants 0.462002 neutropenic cancer patients 0.462006	CLICK HERE
1490	National Cancer Institute	Html	en	Hypopharyngeal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of hypopharyngeal cancer.	statistically significant survival 0.552817 pharynx cancer incidence 0.54678 hypopharyngeal SCCs 0.568302 United States 0.594562 Multiple primary tumors 0.590618 hypopharyngeal wall tumors 0.623965 neck squamous cell 0.598149 PUBMED Abstract 0.631322 pharyngeal cancer 0.54424 5-year disease-free survival 0.561931 Otolaryngol Head Neck 0.607335 squamous cell 0.712263 hypopharyngeal carcinomas 0.629276 neck cancer patients 0.603767 Cancer Res 0.688393 squamous cell cancer 0.573486 hypopharyngeal tumor 0.566864 Abstract 0.707746 pyriform sinus 0.633965 functional larynx 0.541602 patients 0.659221 Hypopharyngeal carcinoma 0.566532 induction chemotherapy arm 0.707576 hypopharyngeal squamous cell 0.623336	squamous cell carcinomas 0.681165 hypopharyngeal SCC 0.56973 upper alimentary tract 0.554127 Natl Cancer Inst 0.619483 pyriform sinus cancer 0.551602 immediate surgery arm 0.623979 neoadjuvant chemotherapy 0.990124 field cancerization 0.600816 hypopharyngeal cancer. 0.653244 significant survival advantage 0.54752 neck cancer 0.685166 Clin Cancer Res 0.614389 radiation therapy 0.868288 Head Neck Surg 0.701435 hypopharyngeal cancers 0.604268 squamous carcinoma 0.542607 induction chemotherapy 0.745083 posterior pharyngeal wall 0.598262 hypopharyngeal cancer 0.866148 prospective randomized trial 0.63031 retrospective study 0.58561 squamous cell carcinoma 0.669554 standard adjuvant therapy 0.638264	CLICK HERE
1635	National Cancer Institute	Html	en	Cancell/Cantron/Protocel (PDQ®)–Patient Version	Expert-reviewed information summary about the use of Cancell/Entelev as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	treatment 0.59635 peer-reviewed scientific journals 0.520434 cancer treatment 0.437142 cancer prevention 0.377301 Complementary Therapies Editorial 0.493039 United States 0.466761 Drug Administration 0.651254 Cancer Information Specialist 0.403618 cancer cells 0.478684 Cancer Information Service 0.547985 liquid mixture Cancell 0.377167 PDQ cancer information 0.676104 Cancer Complementary 0.434191 CAM therapies 0.389658 Cancell 0.664087 treatment clinical trials 0.370761 National Cancer Institute 0.97945 studies 0.373926 clinical trials 0.769435 alternative medicine 0.540927 U.S. Food 0.518657 conventional treatment 0.383649 health care 0.363873 cancer information summary 0.557509	scientific journals 0.541722 alternative cancer therapies 0.42141 Federal Trade Commission 0.393843 National Institutes 0.378494 clinical trial 0.410446 National Center 0.359319 CAM cancer research 0.395503 new treatment 0.357379 breast cancer prevention 0.372403 PDQ health 0.366183 cancer patients 0.43176 Cancer Care page 0.374735 health 0.389384 NCI’s PDQ 0.383229 PDQ summary 0.396491 Integrative Health 0.358164 NCI PDQ cancer 0.499567 cancer information database 0.420231 alternative therapies 0.478182 cancer information summaries 0.420966 Therapies Editorial Board 0.444837 research studies 0.372726 conventional treatments 0.361723	CLICK HERE
1890	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno (mama).	estadio lllC 0.524041 siguientes procedimientos 0.510716 siguientes aspectos 0.534365 causa efectos 0.516747 estadio lllB 0.524512 estadio lllA 0.524967 rayos x 0.508877 causó hinchazón 0.508591 cuáles lesiones 0.508991 Breast Cancer Risk 0.519727 epidérmico humano tipo 0.51911 carcinoma lobulillar 0.618686 crecimiento llamada her2 0.513006 cuerpo llamada ecograma 0.530459 pared torácica.ampliar mastectomía 0.517551 siguientes estadios 0.514163 proteína tipo factor 0.510936 células madre 0.671831 estadio iv 0.594708 ganglio linfático centinela 0.990128 Oncotype DX 0.510563 estadio ib 0.547143 prueba ayuda 0.524997 enlace drugs approved 0.56421 estadio ia 0.546556	mama.ampliar cirugía 0.509968 CLIS.Ampliar Carcinoma lobulillar 0.520349 efectos tardíos 0.515275 proteína her2 0.510017 Características genéticas 0.510197 bulbos minúsculos 0.511767 Breast Cancer Treatment 0.519669 cuántos genes 0.511329 incisión separada.ampliar mastectomía 0.517497 estadio iiia 0.543785 antecedentes familiares 0.532316 cabo pruebas 0.51404 estadio iiic 0.596075 estadio llB 0.525023 estadio llA 0.525437 Gynecologic Cancers 0.511174 mama.ampliar mamografía 0.511179 proteína llamada mTOR 0.510238 Breast Cancer 0.623769 sección cáncer 0.744984 pequeñas llamadas lobulillos 0.518854 genes brca1 0.512161 siguientes pruebas 0.535819 siguientes sumarios 0.517679	CLICK HERE
1975	National Cancer Institute	Html	es	Etapa final de la vida (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre lo que debe ser el cuidado desde los últimos días hasta las últimas horas de vida, esto incluye los síntomas comunes, dilemas éticos que podrían surgir, y la función que desempeña el oncólogo en proveer cuidados al paciente y su familia durante este tiempo.	palliative care experts 0.23431 with medical care 0.241191 discuss palliative care 0.233699 Symptom Assessment 0.232929 puntaje pps 0.250501 Chisholm G 0.239654 impending death 0.225195 American Cancer Society 0.325883 mioclonía inducida 0.230408 signos tardíos 0.255455 cancer care 0.288204 Cancer Patients Admitted 0.244551 Early palliative care 0.234581 Palliative Care Units 0.231229 cancer patients 0.700067 intensidad promedio 0.222271 Palliative Performance Scale 0.307144 PDQ Delirium 0.245083 respiración cheyne-stokes 0.226557 Symptom Assessment Scale 0.224548 End-of-Life Cancer Care 0.259456 hospitalized patients with 0.234983 patients with 0.788026 determinados pacientes 0.252968 Pain Symptom Manage 0.940988	care cancer 0.276344 delirium hiperactivo 0.272295 Santos R 0.261547 cohort study 0.227764 patients with metastatic 0.238354 Cancer Facts 0.237968 palliative care 0.397902 Morita T 0.262872 end-of-life discussion 0.224231 Hosp Palliat Care 0.228606 critical care setting 0.224616 treating delirium 0.237587 ill adult patients 0.223449 correlations with quality 0.226302 clinical signs 0.22445 canadian tertiary care 0.2263 Intern Med 0.224374 Clin Oncol 0.327109 Bruera E 0.232399 terminal care 0.223061 systematic review 0.239239 medical care 0.24121 spiritual care 0.22381 Care Med 0.223485	CLICK HERE
3653	National Cancer Institute	Html	es	Cannabis y canabinoides (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso del Cannabis y canabinoides para el tratamiento de los efectos secundarios relacionados con el tratamiento del cáncer como la náusea y el vómito.	suficiente información 0.303746 American Academy 0.304933 salud masculina 0.30438 Controlled Substances Act 0.309374 estado.ampliar mapa 0.305022 NCI Best Case 0.309795 Ley Boggs 0.304951 ratones modelo 0.329727 Asia central 0.304897 datos bibliográficos pubmed 0.306457 principal canabinoide 0.317402 continuas preocupaciones 0.305444 Instituto Nacional 0.356831 distintos métodos 0.304585 Salud Complementaria 0.311676 Asociación Médica Americana 0.308343 complementarias revisa 0.305401 huésped aguda 0.30517 posibles efectos 0.307656 siglo xix 0.305316 Estados Unidos 0.923075 Investigational New Drug 0.308776 ¿Los beneficios 0.303644 Centro Nacional 0.308445 células madre 0.307765	New Hampshire Avenue 0.305866 creciente interés 0.305364 Drug Administration 0.303686 vía oral 0.438627 medicamentos canabinoides 0.315665 lista i 0.304143 Marijuana Tax Act 0.30965 Men's Health Study 0.308077 siguientes riesgos 0.303989 suficientes pruebas 0.305693 Visuals Online 0.304212 sistema nervioso central 0.330645 Physician Data Query 0.323581 libre uso 0.304331 principal ingrediente 0.304814 receptores canabinoides 0.313898 posibles beneficios 0.304408 página manejo 0.303972 ¿El tratamiento 0.309063 planta cannabis 0.341326 potencial alto 0.304956 medicina complementaria 0.465284 largo tiempo 0.303689 ¿el cannabis 0.355862	CLICK HERE
16684	National Cancer Institute	Html	en	Immunotherapy	Immunotherapy is treatment that helps your immune system fight cancer. Get information about the different types of immunotherapy and what you can expect during treatment.	different ways 0.281527 fatal allergic reactions 0.264895 Certain immunotherapies 0.259316 treatment vaccines 0.275288 cancer cells 0.951751 new healthy cells 0.412417 type 0.312586 adult cancer treatment 0.355067 immune system fight 0.336993 cancer treatment summaries 0.489214 body’s cells 0.328519 white blood cells 0.50706 immune response 0.442108	bladder cancer 0.215882 immunotherapy 0.916869 car t-cell therapy 0.510597 white blood cell 0.291068 biological therapy 0.305661 immune cells 0.541167 normal immune responses 0.430369 immunotherapies 0.36897 different types 0.290719 early skin cancer 0.309312 body fight infections 0.317237 childhood cancer treatment 0.34975 adoptive cell transfer 0.589329	CLICK HERE
16858	National Cancer Institute	Html	en	Monitoring Research Grant Awards	NCI grants management staff regularly monitor individual grants within each budget period and within the overall project period.	program director 0.901745 overall project period 0.737705 Comptroller General 0.577687 documents 0.447442 Grants management officer 0.721935 grants management specialist 0.810551 federal regulation 0.560169 HHS awarding agency 0.720873 NCI staff work 0.714177 assessment 0.459846 progress reports 0.591992 budget period 0.591377 review 0.454674 weaknesses 0.464168 grants management 0.917818 telephone numbers 0.566417 financial reports 0.599567 required retention period 0.705874 reasonable access 0.563534 grant awards 0.568767 responsible GMS 0.614785 award process 0.554431 approved project 0.590335 recipients 0.469243 recipient cash expenditure 0.886855	NCI grants management 0.812999 problems 0.44631 recipient institution 0.874163 United States 0.564008 records 0.447146 audit reports 0.592365 site visits 0.586368 scientific progress 0.547344 Inspector General 0.563508 mutually agreeable course 0.708418 recipient’s inability 0.723309 internal controls 0.570063 Expenditure patterns 0.599349 financial systems 0.589323 pass-through entity 0.56408 monitors individual grants 0.762977 applicant organization 0.594032 unrestricted access 0.5713 principal investigator 0.553317 financial management 0.584417 specific guidelines 0.567884 management systems 0.560429 economic policy 0.555241 grant expenditures 0.689873	CLICK HERE
17291	National Cancer Institute	Html	es	Uso de recursos fidedignos	Información para ayudarle al público a evaluar las fuentes y la credibilidad de la información de salud impresa o disponible en Internet.	información personal 0.935578 siguientes preguntas 0.82336 conocimientos del cáncer que 0.776836 Comisión Federal 0.674467	Clinical Oncology 0.664087 American Society 0.659703 numerosos sitios 0.822963 acepte recomendaciones 0.778707	CLICK HERE